PATENT CLAIM ANALYSIS

Application Number: 15976595
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["530", "387300"]

Abstract:
This invention relates to isolated antibodies which recognize the exosite 1 epitope of thrombin and selectively inhibit thrombin without promoting bleeding. These antibody molecules may be useful in the treatment and prevention of thrombosis, embolism and other conditions mediated by thrombin.

Claim (Index 2):
An isolated or recombinant antibody molecule that specifically binds to the exosite 1 region of thrombin, wherein the antibody molecule inhibits or prevents thrombosis or embolism but does not promote bleeding, and wherein the antibody molecule binds amino acids Q38, R73, T74, and Y76 relative to the amino acid sequence of SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.18919
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14309403', '15434639', '15206896', '14363514', '15348250']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7445437789637317
- 35 USC 102 Novelty (BERT): 0.6157920973649237
- Combined Prediction Score: 0.7316686108038509
- Mean Citation Score: 516.9121240000002
- Max Citation Score: 603.5468
- Similarity Product: 479.67240175399775

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test